Published in PLoS One on August 24, 2010
MED12 alterations in both human benign and malignant uterine soft tissue tumors. PLoS One (2012) 1.26
Genome-wide association study identified a narrow chromosome 1 region associated with chicken growth traits. PLoS One (2012) 1.11
Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. PLoS One (2012) 1.05
Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations. Hum Reprod Update (2014) 0.98
The role of progesterone signaling in the pathogenesis of uterine leiomyoma. Mol Cell Endocrinol (2011) 0.97
Identification of pathogenesis-related microRNAs in hepatocellular carcinoma by expression profiling. Oncol Lett (2012) 0.95
miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8. Mol Endocrinol (2012) 0.91
Uterine fibroids: pathogenesis and interactions with endometrium and endomyometrial junction. Obstet Gynecol Int (2013) 0.87
Tissue-specific stem cells in the myometrium and tumor-initiating cells in leiomyoma. Biol Reprod (2014) 0.83
Inactivation of AKT induces cellular senescence in uterine leiomyoma. Endocrinology (2014) 0.82
An integrative genomic and transcriptomic analysis reveals potential targets associated with cell proliferation in uterine leiomyomas. PLoS One (2013) 0.82
Integrated analysis of long noncoding RNAs and mRNAs reveals their potential roles in the pathogenesis of uterine leiomyomas. Oncotarget (2014) 0.82
miRConnect 2.0: identification of oncogenic, antagonistic miRNA families in three human cancers. BMC Genomics (2013) 0.81
Differences in miRNA expression profiles between GIST and leiomyoma in human samples acquired by submucosal tunneling biopsy. Endosc Int Open (2015) 0.79
MicroRNA expression in Epstein-Barr virus-associated post-transplant smooth muscle tumours is related to leiomyomatous phenotype. Clin Sarcoma Res (2013) 0.79
Integrated data analysis reveals uterine leiomyoma subtypes with distinct driver pathways and biomarkers. Proc Natl Acad Sci U S A (2016) 0.78
Non-coding RNAs in Uterine Development, Function and Disease. Adv Exp Med Biol (2016) 0.77
MicroRNAs as Biomarkers in Cancer. Diagnostics (Basel) (2013) 0.77
Fine mapping of the uterine leiomyoma locus on 1q43 close to a lncRNA in the RGS7-FH interval. Endocr Relat Cancer (2015) 0.77
Role of miR-182 in response to oxidative stress in the cell fate of human fallopian tube epithelial cells. Oncotarget (2015) 0.76
Telocytes in female reproductive system (human and animal). J Cell Mol Med (2016) 0.75
MiR-424-5p participates in esophageal squamous cell carcinoma invasion and metastasis via SMAD7 pathway mediated EMT. Diagn Pathol (2016) 0.75
MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyoma. Reprod Biol Endocrinol (2016) 0.75
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell (2005) 96.87
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
Prediction of mammalian microRNA targets. Cell (2003) 53.70
Combinatorial microRNA target predictions. Nat Genet (2005) 50.48
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature (2005) 48.95
miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res (2006) 39.25
TM4: a free, open-source system for microarray data management and analysis. Biotechniques (2003) 38.02
MicroRNA gene expression deregulation in human breast cancer. Cancer Res (2005) 27.56
Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96
MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A (2004) 14.59
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A (2004) 13.66
Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science (2007) 12.42
miRNAs, cancer, and stem cell division. Cell (2005) 12.15
microRNAs as oncogenes and tumor suppressors. Dev Biol (2006) 10.68
The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev (2007) 10.15
MAP kinase signalling pathways in cancer. Oncogene (2007) 8.52
Cell-type-specific signatures of microRNAs on target mRNA expression. Proc Natl Acad Sci U S A (2006) 7.11
How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev (2005) 5.22
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ (2009) 3.94
Small RNAs: classification, biogenesis, and function. Mol Cells (2005) 3.59
Let-7 expression defines two differentiation stages of cancer. Proc Natl Acad Sci U S A (2007) 3.59
Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect (2003) 2.98
Role for DNA methylation in the regulation of miR-200c and miR-141 expression in normal and cancer cells. PLoS One (2010) 2.55
A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer (2007) 2.35
Retracted Differential expression of microRNAs in myometrium and leiomyomas and regulation by ovarian steroids. J Cell Mol Med (2007) 2.24
Transforming growth factor-beta and microRNA:mRNA regulatory networks in epithelial plasticity. Cells Tissues Organs (2007) 1.95
Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition. Gynecol Oncol (2009) 1.84
Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers. J Oncol (2009) 1.84
Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids. Genes Chromosomes Cancer (2004) 1.65
Global analysis of microRNA target gene expression reveals that miRNA targets are lower expressed in mature mouse and Drosophila tissues than in the embryos. Nucleic Acids Res (2006) 1.58
Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res (2008) 1.52
Loss of tuberin from cerebral tissues with tuberous sclerosis and astrocytoma. Ann Neurol (1996) 1.46
Detection of a microRNA signal in an in vivo expression set of mRNAs. PLoS One (2007) 1.40
Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod (2005) 1.32
Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology (2004) 1.31
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. Fertil Steril (2007) 1.25
Immortalization of human uterine leiomyoma and myometrial cell lines after induction of telomerase activity: molecular and phenotypic characteristics. Lab Invest (2002) 1.22
Ethnic differences in expression of the dysregulated proteins in uterine leiomyomata. Hum Reprod (2005) 1.15
Gene expression profile of leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. J Soc Gynecol Investig (2003) 1.13
Molecular characterization of uterine fibroids and its implication for underlying mechanisms of pathogenesis. Fertil Steril (2004) 1.12
Expression profile of the tumorigenic factors associated with tumor size and sex steroid hormone status in uterine leiomyomata. Fertil Steril (2005) 0.99
Expression profile of tuberin and some potential tumorigenic factors in 60 patients with uterine leiomyomata. Mod Pathol (2005) 0.94
Fibroids display an anti-angiogenic gene expression profile when compared with adjacent myometrium. Mol Hum Reprod (2003) 0.87
Tuberin immunohistochemistry in brain, kidneys and heart with or without tuberous sclerosis. Acta Neuropathol (1997) 0.82
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature (2007) 16.95
Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell (2008) 7.65
Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell (2006) 5.88
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo. Nat Genet (2003) 5.82
MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells. Cancer Res (2007) 5.25
Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor. Proc Natl Acad Sci U S A (2009) 4.00
Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med (2008) 3.98
Tissue-specific and reversible RNA interference in transgenic mice. Nat Genet (2007) 2.54
The histone variant macroH2A suppresses melanoma progression through regulation of CDK8. Nature (2010) 2.49
Control of chromosome stability by the beta-TrCP-REST-Mad2 axis. Nature (2008) 2.46
Declining p53 function in the aging process: a possible mechanism for the increased tumor incidence in older populations. Proc Natl Acad Sci U S A (2007) 2.36
A micro-RNA signature associated with race, tumor size, and target gene activity in human uterine leiomyomas. Genes Chromosomes Cancer (2007) 2.35
Cellular senescence in usual type uterine leiomyoma. Fertil Steril (2009) 2.34
miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis. Cancer Cell (2011) 2.30
Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proc Natl Acad Sci U S A (2004) 2.19
Diversity of 16S rRNA genes within individual prokaryotic genomes. Appl Environ Microbiol (2010) 1.93
Role of desumoylation in the development of prostate cancer. Neoplasia (2006) 1.90
Stimulation of prostate cancer cellular proliferation and invasion by the androgen receptor co-activator ARA70. Am J Pathol (2007) 1.77
Global transcriptional profile of Mycobacterium tuberculosis during THP-1 human macrophage infection. Infect Immun (2007) 1.66
Derivation of sarcomas from mesenchymal stem cells via inactivation of the Wnt pathway. J Clin Invest (2007) 1.66
Role of the chromobox protein CBX7 in lymphomagenesis. Proc Natl Acad Sci U S A (2007) 1.65
Melanoma MicroRNA signature predicts post-recurrence survival. Clin Cancer Res (2010) 1.59
CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists. J Pathol (2015) 1.54
Gene expression profiles and transcription factors involved in parathyroid hormone signaling in osteoblasts revealed by microarray and bioinformatics. J Biol Chem (2003) 1.53
In vivo pharmacokinetics and regulation of gene expression profiles by isothiocyanate sulforaphane in the rat. J Pharmacol Exp Ther (2004) 1.53
Conduction slowing contributes to spontaneous ventricular arrhythmias in intrinsically active murine RyR2-P2328S hearts. J Cardiovasc Electrophysiol (2012) 1.53
Antiproliferative effects by Let-7 repression of high-mobility group A2 in uterine leiomyoma. Mol Cancer Res (2008) 1.52
Mifepristone inhibits GRβ coupled prostate cancer cell proliferation. J Urol (2012) 1.51
Global analysis of Pub1p targets reveals a coordinate control of gene expression through modulation of binding and stability. Mol Cell Biol (2005) 1.50
Evidence for complex interactions of stress-associated regulons in an mprAB deletion mutant of Mycobacterium tuberculosis. Microbiology (2007) 1.46
Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet (2004) 1.45
BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy. Cancer Res (2013) 1.43
A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas. Am J Pathol (2008) 1.43
Structural determinants of tissue tropism and in vivo pathogenicity for the parvovirus minute virus of mice. J Virol (2005) 1.41
MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma. J Pathol (2012) 1.38
Cell-specific regulation of androgen receptor phosphorylation in vivo. J Biol Chem (2005) 1.38
Human cytomegalovirus US28 found in glioblastoma promotes an invasive and angiogenic phenotype. Cancer Res (2011) 1.36
LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion. Cancer Res (2009) 1.34
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer (2010) 1.31
Mycobacterium tuberculosis sigma factor E regulon modulates the host inflammatory response. J Infect Dis (2008) 1.30
HMGA2 overexpression-induced ovarian surface epithelial transformation is mediated through regulation of EMT genes. Cancer Res (2011) 1.27
MicroRNA-22 is induced by vitamin D and contributes to its antiproliferative, antimigratory and gene regulatory effects in colon cancer cells. Hum Mol Genet (2012) 1.26
Distinct nuclear and cytoplasmic functions of androgen receptor cofactor p44 and association with androgen-independent prostate cancer. Proc Natl Acad Sci U S A (2008) 1.23
Activation of the eis gene in a W-Beijing strain of Mycobacterium tuberculosis correlates with increased SigA levels and enhanced intracellular growth. Microbiology (2009) 1.22
The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol Endocrinol (2005) 1.19
Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis. FASEB J (2012) 1.17
Developing a multidisciplinary prospective melanoma biospecimen repository to advance translational research. Am J Transl Res (2009) 1.17
Tumor promotion by Mdm2 splice variants unable to bind p53. Cancer Res (2003) 1.17
Molecular genetics of hepatocellular neoplasia. Am J Transl Res (2010) 1.16
Molecular and immunohistochemical evidence for the origin of uterine leiomyosarcomas from associated leiomyoma and symplastic leiomyoma-like areas. Mod Pathol (2009) 1.15
Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol (2010) 1.15
Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication. J Virol (2005) 1.13
EZ-Retrieve: a web-server for batch retrieval of coordinate-specified human DNA sequences and underscoring putative transcription factor-binding sites. Nucleic Acids Res (2002) 1.13
Clonal progression of prostate cancers from Gleason grade 3 to grade 4. Cancer Res (2012) 1.12
Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion. Clin Cancer Res (2010) 1.11
HMGA2: a potential biomarker complement to P53 for detection of early-stage high-grade papillary serous carcinoma in fallopian tubes. Am J Surg Pathol (2010) 1.11
Racial disparity of epidermal growth factor receptor expression in prostate cancer. J Clin Oncol (2004) 1.10
Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion. J Cell Mol Med (2008) 1.09
HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma. Mod Pathol (2010) 1.08
Prostaglandin J2 alters pro-survival and pro-death gene expression patterns and 26 S proteasome assembly in human neuroblastoma cells. J Biol Chem (2006) 1.08
Identification of direct transcriptional targets of the Kaposi's sarcoma-associated herpesvirus Rta lytic switch protein by conditional nuclear localization. J Virol (2008) 1.08
Expression of Long-chain Fatty Acyl-CoA Synthetase 4 in Breast and Prostate Cancers Is Associated with Sex Steroid Hormone Receptor Negativity. Transl Oncol (2010) 1.08
Serum microRNAs as biomarkers for recurrence in melanoma. J Transl Med (2012) 1.06
Integrative genomics identifies molecular alterations that challenge the linear model of melanoma progression. Cancer Res (2011) 1.06
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis (2012) 1.06
Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma. PLoS One (2012) 1.05
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer (2014) 1.03
Roles of the androgen receptor cofactor p44 in the growth of prostate epithelial cells. J Mol Endocrinol (2006) 1.02
Comprehensive genome-wide comparison of DNA and RNA level scan using microarray technology for identification of candidate cancer-related genes in the HL-60 cell line. Cancer Genet Cytogenet (2003) 1.02
Molecular mechanisms involving prostate cancer racial disparity. Am J Transl Res (2009) 1.02
Tumor suppressor function of androgen receptor coactivator ARA70alpha in prostate cancer. Am J Pathol (2010) 1.02
Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. J Mol Endocrinol (2006) 1.01
Proliferation dynamics in cultured skin fibroblasts from Down syndrome subjects. Free Radic Biol Med (2005) 1.01
Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutat Res (2012) 1.00
Increased expression of histone deacetylaces (HDACs) and inhibition of prostate cancer growth and invasion by HDAC inhibitor SAHA. Am J Transl Res (2009) 0.99
Proteomics, pathway array and signaling network-based medicine in cancer. Cell Div (2009) 0.99
Histology-specific microRNA alterations in melanoma. J Invest Dermatol (2012) 0.99
Copy number and gene expression differences between African American and Caucasian American prostate cancer. J Transl Med (2010) 0.99
Low-grade papillary urothelial carcinoma of the urinary bladder: a clinicopathologic analysis of a post-World Health Organization/International Society of Urological Pathology classification cohort from a single academic center. Arch Pathol Lab Med (2010) 0.99
Protein arginine methyltransferase 5 functions in opposite ways in the cytoplasm and nucleus of prostate cancer cells. PLoS One (2012) 0.98
Immunohistochemical panel to identify the primary site of invasive micropapillary carcinoma. Am J Surg Pathol (2009) 0.98
Differences in clinicopathologic features of prostate cancer between black and white patients treated in the 1990s and 2000s. Urology (2006) 0.98
Berberine radiosensitizes human esophageal cancer cells by downregulating homologous recombination repair protein RAD51. PLoS One (2011) 0.97
A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy. Am J Pathol (2010) 0.97